NovaBridge Biosciences (NBP) Form 10-K Annual Reports
NovaBridge Biosciences (NBP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NBP
CIK: 1778016
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerChristopher Kean
Audit LocationFlorham Park, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-13 | 2026-10-13 | 6-K | 0001193125-26-419669 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-17 | 4 Filing | 0002089237-26-000008 | View SEC Doc Filr Page |
| 144 | 2026-09-18 | — | 144 Filing | 0001973379-26-000341 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-09 | 4 Filing | 0002109966-26-000008 | View SEC Doc Filr Page |
| 3 | 2026-09-10 | 2026-09-08 | 3 Filing | 0002108597-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-09-09 | — | 144 Filing | 0001973379-26-000336 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-03 | 4 Filing | 0002109966-26-000006 | View SEC Doc Filr Page |
| 6-K | 2026-09-08 | 2026-09-08 | 6-K | 0001193125-26-384356 | View SEC Doc Filr Page |
| 6-K | 2026-09-08 | 2026-09-08 | 6-K | 0001193125-26-384355 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-30 | 4 Filing | 0002114309-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-22 | 4 Filing | 0001992908-26-000013 | View SEC Doc Filr Page |
| 6-K | 2026-08-20 | 2026-06-30 | 6-K | 0001193125-26-357819 | View SEC Doc Filr Page |
| 6-K | 2026-08-20 | 2026-08-20 | 6-K | 0001193125-26-357817 | View SEC Doc Filr Page |
| S-8 | 2026-08-17 | — | S-8 | 0001193125-26-353173 | View SEC Doc Filr Page |
| 6-K | 2026-07-24 | 2026-07-24 | 6-K | 0001193125-26-316242 | View SEC Doc Filr Page |
| 6-K | 2026-07-17 | 2026-07-13 | 6-K | 0001193125-26-306688 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 Filing | 0002126029-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 Filing | 0002114156-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | 4 Filing | 0002024011-26-000006 | View SEC Doc Filr Page |
| 3 | 2026-07-08 | 2026-07-01 | 3 Filing | 0002024011-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-04 | 4 Filing | 0002114309-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-29 | 4 Filing | 0001885756-26-000005 | View SEC Doc Filr Page |
| 6-K | 2026-06-29 | 2026-06-29 | 6-K | 0001193125-26-286812 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | 4 Filing | 0002109966-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 Filing | 0002089237-26-000006 | View SEC Doc Filr Page |